Literature DB >> 24122011

Acute exposure of methylglyoxal leads to activation of KATP channels expressed in HEK293 cells.

Yang Yang1, Anuhya S Konduru2, Ningren Cui2, Lei Yu2, Timothy C Trower2, Weiwei Shi2, Yun Shi2, Chun Jiang2.   

Abstract

AIM: Highly reactive carbonyl methylglyoxal (MGO) is one of the metabolites excessively produced in diabetes. We have showed that prolonged exposure of vascular smooth muscle cells to MGO leads to instability of the mRNA encoding ATP-sensitive potassium (KATP) channel. In the present study we investigated the effects of MGO on the activity of KATP channels.
METHODS: Kir6.1/ SUR2B, Kir6.2/SUR2B or Kir6.2Δ36 (a truncated Kir6.2 isoform) alone was expressed in HEK293 cells. Whole-cell currents were recorded in the cells with an Axopatch 200B amplifier. Macroscopic currents and single-channel currents were recorded in giant inside-out patches and normal inside-out patches, respectively. Data were analyzed using Clampfit 9 software.
RESULTS: The basal activity of Kir6.1/SUR2B channels was low. The specific KATP channel opener pinacidil (10 μmol/L) could fully activate Kir6.1/SUR2B channels, which was inhibited by the specific KATP channel blocker glibenclamide (10 μmol/L). MGO (0.1-10 mmol/L) dose-dependently activated Kir6.1/SUR2B channels with an EC50 of 1.7 mmol/L. The activation of Kir6.1/SUR2B channels by MGO was reversible upon washout, and could be inhibited completely by glibenclamide. Kir6.2Δ36 channels expressed in HEK293 cells could open automatically, and the channel activity was enhanced in the presence of MGO (3 mmol/L). Single channel recordings showed that MGO (3 mmol/L) markedly increased the open probability of Kir6.1/SUR2B channels, leaving the channel conductance unaltered.
CONCLUSION: Acute application of MGO activates KATP channels through direct, non-covalent and reversible interactions with the Kir6 subunits.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24122011      PMCID: PMC4075750          DOI: 10.1038/aps.2013.122

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  41 in total

1.  Protons activate homomeric Kir6.2 channels by selective suppression of the long and intermediate closures.

Authors:  J Wu; H Xu; Z Yang; Y Wang; J Mao; C Jiang
Journal:  J Membr Biol       Date:  2002-11-15       Impact factor: 1.843

Review 2.  Carbonyl toxicology and Alzheimer's disease.

Authors:  Matthew J Picklo; Thomas J Montine; Venkataraman Amarnath; M Diana Neely
Journal:  Toxicol Appl Pharmacol       Date:  2002-11-01       Impact factor: 4.219

3.  Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1.

Authors:  Takashi Miki; Masashi Suzuki; Tadao Shibasaki; Hiroko Uemura; Toshiaki Sato; Kaori Yamaguchi; Haruhiko Koseki; Toshihiko Iwanaga; Haruaki Nakaya; Susuma Seino
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

4.  Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl)lysine-modified albumin.

Authors:  Naila Ahmed; Ognian K Argirov; Harjit S Minhas; Carlos A A Cordeiro; Paul J Thornalley
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 5.  Oxidative stress and potassium channel function.

Authors:  Yanping Liu; David D Gutterman
Journal:  Clin Exp Pharmacol Physiol       Date:  2002-04       Impact factor: 2.557

6.  Prolonged exposure to methylglyoxal causes disruption of vascular KATP channel by mRNA instability.

Authors:  Yang Yang; Shanshan Li; Anuhya S Konduru; Shuang Zhang; Timothy C Trower; Weiwei Shi; Ningren Cui; Lei Yu; Yali Wang; Daling Zhu; Chun Jiang
Journal:  Am J Physiol Cell Physiol       Date:  2012-09-12       Impact factor: 4.249

Review 7.  The coronary circulation in diabetes: influence of reactive oxygen species on K+ channel-mediated vasodilation.

Authors:  Yanping Liu; David D Gutterman
Journal:  Vascul Pharmacol       Date:  2002-01       Impact factor: 5.773

8.  Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels.

Authors:  William A Chutkow; Jielin Pu; Matthew T Wheeler; Tomoyuki Wada; Jonathan C Makielski; Charles F Burant; Elizabeth M McNally
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

9.  Diabetes mellitus impairs vasodilation to hypoxia in human coronary arterioles: reduced activity of ATP-sensitive potassium channels.

Authors:  Hiroto Miura; Ruth E Wachtel; Fausto R Loberiza; Takashi Saito; Mamoru Miura; Alfred C Nicolosi; David D Gutterman
Journal:  Circ Res       Date:  2003-02-07       Impact factor: 17.367

10.  S-Glutathionylation underscores the modulation of the heteromeric Kir4.1-Kir5.1 channel in oxidative stress.

Authors:  Xin Jin; Lei Yu; Yang Wu; Shuang Zhang; Zhenda Shi; Xianfeng Chen; Yang Yang; Xiaoli Zhang; Chun Jiang
Journal:  J Physiol       Date:  2012-08-20       Impact factor: 5.182

View more
  4 in total

1.  Methylglyoxal triggers human aortic endothelial cell dysfunction via modulation of the KATP/MAPK pathway.

Authors:  Yihan Wang; Leo M Hall; Marisa Kujawa; Hainan Li; Xiang Zhang; Megan O'Meara; Tomomi Ichinose; Jie-Mei Wang
Journal:  Am J Physiol Cell Physiol       Date:  2019-04-17       Impact factor: 4.249

Review 2.  Metabolic Shades of S-D-Lactoylglutathione.

Authors:  Miklós Péter Kalapos; Cinzia Antognelli; Lidia de Bari
Journal:  Antioxidants (Basel)       Date:  2022-05-20

Review 3.  Are sensory TRP channels biological alarms for lipid peroxidation?

Authors:  Seung-In Choi; Sungjae Yoo; Ji Yeon Lim; Sun Wook Hwang
Journal:  Int J Mol Sci       Date:  2014-09-17       Impact factor: 5.923

Review 4.  Dicarbonyl Stress and S-Glutathionylation in Cerebrovascular Diseases: A Focus on Cerebral Cavernous Malformations.

Authors:  Cinzia Antognelli; Andrea Perrelli; Tatiana Armeni; Vincenzo Nicola Talesa; Saverio Francesco Retta
Journal:  Antioxidants (Basel)       Date:  2020-02-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.